Welcome to episode 13 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and Trevor Abes each deliver a 2.5-minute stock pick related to recent news stories with investment implications.
Here’s Jon’s rundown for episode 13:
- What is going on with MediPharm Labs? (Stockhouse).
- Jon’s stock pick for this week is MediPharm Labs (TSX:LABS), a developer and manufacturer of pharmaceutical-grade cannabis concentrates, active pharmaceutical ingredients and advanced derivative products.
- At the time of writing, MediPharm stock last traded at C$0.075, giving back 6.25 per cent year-over-year and 95.99 per cent since 2020.
Here’s Trevor’s:
- Diversify away from cannabis retail with this technology stock (Stockhouse).
- Cannabix Technologies Enters Contract Manufacturing Agreement with Price Industries for BreathLogix Devices (Stockhouse).
- Trevor’s stock pick, Cannabix Technologies (CSE:BLO), is a developer of cannabis and alcohol breathalyzer technologies.
- At the time of writing, Cannabix stock last traded at C$0.60, giving back 16.67 per cent year-over-year while remaining up by 36.36 per cent since 2020.
Here’s a list of past episodes:
- Episode 1: Lithium and AI.
- Episode 2: Envelopes and space travel.
- Episode 3: Booze and concrete.
- Episode 4: Graphite and GameStop.
- Episode 5: High-flying stocks.
- Episode 6: Shopify and First Mining Gold.
- Episode 7: Galaxy Digital and Liberty Defense.
- Episode 8: Dollarama and Standard Lithium.
- Episode 9: Cancer drugs and corner stores.
- Episode 10: Boeing vs. Bombardier.
- Episode 11: Crypto picks from Consensus 2025.
- Episode 12: Profitable growth picks.
Thanks for listening!
The 5-Minute Investor is on Spotify, YouTube, iHeartRadio, Podbean, Stockhouse or wherever finer podcasts are found.
Join the discussion: Find out what investors are saying about The 5-Minute Investor Podcast and this week’s stock picks on the MediPharm Labs Corp. and Cannabix Technologies Inc. Bullboards and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this podcast is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
(Top image: Adobe Stock)
